Aortyx
Noemí Balà Palasí's work experience includes the role of CTO & Founder at Aortyx since October 2018. Prior to this, they served as a Visiting Student at the Massachusetts Institute of Technology from April 2017 to September 2017, where they focused on designing a medical device to treat aortic dissections. Noemí also worked on developing a new graft using a biocompatible material to improve patient outcomes. Earlier in their career, they completed a final degree project at IQAC-CSIC from February 2015 to September 2015, during which they developed an analytical method for monitoring the activity of a specific protein.
Noemí Balà Palasí completed their education in a chronological order as follows:
From 2010 to 2015, they obtained their Bachelor's degree in Chemistry from Universitat de Barcelona.
From 2015 to 2017, they pursued a Master's degree in Pharmaceutical Chemistry at Universitat Ramon Llull.
Finally, from 2018 to 2022, Noemí Balà Palasí completed their Doctorate in Chemical Engineering at Universitat Ramon Llull.
This person is not in any teams
Aortyx
Aortyx is a pioneer company founded by researchers from the IQS School of Engineering and the Hospital Clínic de Barcelona that aims at providing a new generation of endovascular devices to treat vascular diseases. Our technology focuses on tissue regeneration by mimicking the aorta biomechanical environment. It provides a suitable milieu for cellmigration and proliferation in a bioresorbable platform that minimizes differences with the natural dynamics of the aorta.